Moderna, Inc.

Moderna, Inc.verified

MRNA

Price:

$133.27

Market Cap:

$51.07B

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; ca...[Read more]

Industry

Biotechnology

IPO Date

2018-12-07

Stock Exchange

NASDAQ

Ticker

MRNA

The PE Ratio as of June 2024 (TTM) for Moderna, Inc. (MRNA) is -8.68

According to Moderna, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -8.68. This represents a change of -244.83% compared to the average of 5.99 of the last 4 quarters.

Moderna, Inc. (MRNA) Historical PE Ratio (quarterly & annually)

How has MRNA PE Ratio performed in the past?

The mean historical PE Ratio of Moderna, Inc. over the last ten years is -15.00. The current -8.68 PE Ratio has changed 5.69% with respect to the historical average. Over the past ten years (40 quarters), MRNA's PE Ratio was at its highest in in the March 2023 quarter at 187.60. The PE Ratio was at its lowest in in the June 2020 quarter at -51.91.

Quarterly (TTM)
Annual

Average

-15.00

Median

-10.32

Minimum

-53.33

Maximum

8.46

Moderna, Inc. (MRNA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Moderna, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 323.63%

Maximum Annual PE Ratio = 8.46

Minimum Annual Increase = -195.22%

Minimum Annual PE Ratio = -53.33

Quarterly (TTM)
Annual
YearPE RatioChange
2023-8.06-195.22%
20228.460.89%
20218.39-115.73%
2020-53.33323.63%
2019-12.59291.00%
2018-3.22-88.22%
2017-27.33-15.51%

Moderna, Inc. (MRNA) Average PE Ratio

How has MRNA PE Ratio performed in the past?

The current PE Ratio of Moderna, Inc. (MRNA) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

2.93

5-year avg

-11.42

10-year avg

-15.00

Moderna, Inc. (MRNA) PE Ratio vs. Peers

How is MRNA’s PE Ratio compared to its peers?

Moderna, Inc.’s PE Ratio is less than CureVac N.V. (-2.50), less than Novavax, Inc. (-4.84), less than CohBar, Inc. (-0.22), greater than Reata Pharmaceuticals, Inc. (-89.36), less than Ocean Biomedical, Inc. (0), less than Enveric Biosciences, Inc. (-0.25), less than Hepion Pharmaceuticals, Inc. (-0.18), less than Elevation Oncology, Inc. (-0.14), less than AVROBIO, Inc. (-3.32), less than Rain Therapeutics Inc. (2.10), less than Krystal Biotech, Inc. (-0.62), less than Intellia Therapeutics, Inc. (85.64), less than Editas Medicine, Inc. (-4.88), less than Vertex Pharmaceuticals Incorporated (-2.49), less than Beam Therapeutics Inc. (30.02), greater than Ginkgo Bioworks Holdings, Inc. (-14.05), less than null (-0.99),

Build a custom stock screener for Moderna, Inc. (MRNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Moderna, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Moderna, Inc. (MRNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Moderna, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Moderna, Inc.'s PE Ratio?

How is the PE Ratio calculated for Moderna, Inc. (MRNA)?

What is the highest PE Ratio for Moderna, Inc. (MRNA)?

What is the 3-year average PE Ratio for Moderna, Inc. (MRNA)?

What is the 5-year average PE Ratio for Moderna, Inc. (MRNA)?

How does the current PE Ratio for Moderna, Inc. (MRNA) compare to its historical average?